Yagi T, Takagi K, Yoshida R, Umeda Y, Nobuoka D, Kuise T, Fujiwara T, Takaki A
Departments of Gastroenterology, Transplant Surgery, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama City, Japan.
Departments of Gastroenterology, Transplant Surgery, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama City, Japan.
Transplant Proc. 2018 May;50(4):1192-1195. doi: 10.1016/j.transproceed.2017.11.078.
When the Budd-Chiari syndrome (BCS) lesion extends to the inferior vena cava (IVC) or the orifices of the hepatic vein, the thickened IVC and/or hepatic vein wall must be removed and IVC reconstruction is required in living-donor liver transplantation (LDLT). In various reports about IVC resection in LDLT for BCS, there are none about left lobe liver transplantation with reconstruction of the retrohepatic IVC (rhIVC). To overcome removal and reconstruction of the rhIVC in LDLT for BCS, we introduced a composite IVC graft that is applicable to both right and left lobe partial liver grafts for LDLT for BCS. Pathogenic IVC was removed together with the native liver between the lower edge of the right atrium and 5 cm above the renal vein junction with the use of venovenous bypass. The e-polytetrafluoroethylene graft was anastomosed to the suprarenal intact IVC. Then the native part was detached at the level of just above the renal junction. The composite graft was inverted and a half rim of the native part of the graft was anastomosed to the posterior wall of the right atrium. Next, the common venous orifice of the left lobe graft was anastomosed to the wall defect which was composed of the anterior wall of the right atrium and the distal end of the native part of the composite graft. In conclusion, our inverted composite graft technique will overcome the weak points of LDLT for BCS, such as incomplete removal of the pathogenic caval wall and reconstruction of the rhIVC.
当布加综合征(BCS)病变延伸至下腔静脉(IVC)或肝静脉开口时,在活体肝移植(LDLT)中必须切除增厚的IVC和/或肝静脉壁,并进行IVC重建。在关于LDLT治疗BCS时IVC切除的各种报道中,尚无关于左叶肝移植并重建肝后IVC(rhIVC)的报道。为了克服LDLT治疗BCS时rhIVC的切除和重建问题,我们引入了一种复合IVC移植物,其适用于LDLT治疗BCS的右叶和左叶部分肝移植物。使用静脉-静脉旁路,在右心房下缘与肾静脉汇合处上方5 cm之间将病变的IVC与天然肝脏一并切除。将e-聚四氟乙烯移植物与肾上腺上方完整的IVC进行吻合。然后在肾静脉汇合处上方水平分离天然部分。将复合移植物翻转,将移植物天然部分的半边缘与右心房后壁进行吻合。接下来,将左叶移植物的共同静脉开口与由右心房前壁和复合移植物天然部分远端组成的壁缺损进行吻合。总之,我们的翻转复合移植物技术将克服LDLT治疗BCS的弱点,如病变腔静脉壁切除不完全和rhIVC重建。